- Home
- / Akers Biosciences
- / Revenue
Akers BiosciencesHeader placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Annual Revenue ($)
Akers Biosciences revenue was $1.58 m in FY, 2019
Quarterly Revenue ($)
| Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.17 m | $1.35 m | $453.31 k | $510.05 k | $966.92 k | $169.47 k | $738.02 k | $956.49 k | $613.2 k | $667.25 k | $1.2 m | $675.83 k | $302.48 k | $526.6 k | $557.09 k | $612.12 k | $464.51 k | $420.81 k | $363.52 k | ($1.89 k) |
Annual Growth Rate (%)
Revenue Breakdown
Business Segment
Akers Biosciences revenue breakdown by business segment: 99.9% from Product and 0.1% from Other
| FY, 2016 | FY, 2015 | |
|---|---|---|
| Product | $2.96 m | $1.79 m |
| License Fees | $3.75 k | $320.56 k |
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.